Statements of Consolidated Income (Loss) - USD ($) $ in Millions		12 Months Ended
		Apr. 30, 2025		Apr. 30, 2024		Apr. 30, 2023
Income Statement [Abstract]
Net sales		$ 8,726.1		$ 8,178.7		$ 8,529.2
Cost of products sold	[1]	5,341.4		5,063.3		5,727.4
Gross Profit		3,384.7		3,115.4		2,801.8
Selling, distribution, and administrative expenses		1,529.0		1,446.2		1,455.0
Amortization		219.3		191.1		206.9
Goodwill impairment charges		1,661.6	[2]	0.0		0.0
Other intangible assets impairment charges		320.9		0.0		0.0
Other special project costs	[1],[3]	35.8		130.2		4.7
Loss (gain) on divestitures – net		310.1		12.9		1,018.5
Other operating expense (income) – net		(18.1)		29.2		(40.8)
Operating Income (Loss)		(673.9)		1,305.8		157.5
Interest expense – net		(388.7)		(264.3)		(152.0)
Other debt gains (charges) – net	[1]	30.2	[3]	(19.5)	[3]	0.0
Other income (expense) – net	[3]	(14.4)		(25.6)		(14.7)
Income (Loss) Before Income Taxes		(1,046.8)		996.4		(9.2)
Income tax expense		184.0		252.4		82.1
Net Income (Loss)		$ (1,230.8)		$ 744.0		$ (91.3)
Earnings per common share:
Net Income (Loss) (in dollars per share)		$ (11.57)		$ 7.14		$ (0.86)
Net Income (Loss) - Assuming Dilution (in dollars per share)		$ (11.57)		$ 7.13		$ (0.86)

[1] Includes special project costs related to certain divestiture, acquisition, integration, and restructuring activities. For more information, see Note 4: Special Project Costs, Note 5: Reportable Segments, and Note 8: Debt and Financing Arrangements.

[2] Included in goodwill as of April 30, 2025, are accumulated goodwill impairment charges of $1,904.5.

[3] Includes special project costs related to certain divestiture, acquisition, integration, and restructuring activities. For more information, see Note 4: Special Project Costs and Note 8: Debt and Financing Arrangements.